🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult a...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-02-15
Trial ID
NCT05103358
Treatments Being Tested
The purpose of this study is to determine whether ABI-009 will make advance...
Status
Terminated
Location
Ochsner Clinic Foundation
Start Date
2018-11-05
Trial ID
NCT03670030
Treatments Being Tested
This is a phase 1, multi-center, open-label, dose-escalation study of nab-s...
Status
Recruiting
Location
South Texas Accelerated Research Therapeutics, LLC
Start Date
2022-11-23
Trial ID
NCT05661461
Treatments Being Tested
Purpose of this study is to determine appropriate dosing of ABI-009 and eva...
Status
Completed
Location
Columbia University Medical Center
Start Date
2014-04-09
Trial ID
NCT02009332
Treatments Being Tested
This phase I trial studies the side effects and best dose of nanoparticle a...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2017-08-15
Trial ID
NCT02975882
This phase I/II trial studies the side effects and best dose of nab-sirolim...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-04-01
Trial ID
NCT03660930
Treatments Being Tested
This is a prospective, single-center, phase 1 safety study to investigate t...
Status
Completed
Location
Seattle Children's Hospital
Start Date
2018-07-31
Trial ID
NCT03646240
Treatments Being Tested
A phase 2 multi-center investigation of efficacy of nab-sirolimus (formerly...
Status
Completed
Location
Stanford University Medical Center
Start Date
2015-10
Trial ID
NCT02494570
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Withdrawn
Location
Massachusetts General Hospital Cancer Center
Start Date
2019-05-30
Trial ID
NCT03657420
Treatments Being Tested
A phase 1/2 multi-center investigation of nab-sirolimus (also known as ABI-...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2018-07-01
Trial ID
NCT03439462
Treatments Being Tested